MOLECULES 润色咨询

MOLECULES

出版年份：1996 年文章数：35193 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：10.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2021-01-12 Rtase

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！

    10

    展开10条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2022-05-20 ms5000001536683150

    投稿命中率:75.0
    偏重的研究方向：中药单体
    经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2022-03-07 ms6000001633558853

    偏重的研究方向：药理;中药
    经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2020-06-30 65466546561161

    去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2020-02-23 spiritak_34827477

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2019-08-05 桃之妖妖

    请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了153OcDe3069(暂无昵称) 2017-10-31 发表::
    请问大家一般pending review 状态多久进入下一阶段？？？大神们    153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:
    请问大家一般pending review 状态多久进入下一阶段？？？大神们

    153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2022-08-22 1e0c52fcm39(暂无匿称)

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2021-04-20 ms9000001139041689

    偏重的研究方向： 药理
    经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2022-07-15 ms1000000533864290

    想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0<br>偏重的研究方向：中药单体<br>经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药<br>经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800525, encodeId=0f2180052513, content=去年投过一篇综述，两个月接收，中间改了几次，态度挺好的，容易沟通。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a22119108, createdName=65466546561161, createdTime=Tue Jun 30 09:48:49 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585238, encodeId=e81e58523825, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收 编辑态度也很好 总体难度不大 就是版面费略贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Sun Feb 23 20:42:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574422, encodeId=00085e4422f6, content=请问你用了多久呢？我现在投稿以后就是这个状态，已经过了好几天了<span class="quote">153OcDe3069(暂无昵称) 2017-10-31 发表::<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span><span class="quote">153OcDe3069(暂无昵称) 2017-10-31 19:30:00 发表:<br>请问大家一般pending review 状态多久进入下一阶段？？？大神们</span>, beContent=153OcDe3069(暂无昵称) 2017-10-31 发表:: 请问大家一般pending review 状态多久进入下一阶段？？？大神们, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/05/1e2beef086b8985fc951521ecf156cfc.jpg, createdBy=ab6b5134614, createdName=桃之妖妖, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向： 药理 <br>经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？<span class="quote">DZGan 2019-03-29 00:00:00 发表:<br>终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的</span>, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=)]
    2019-08-31 12532bbcm11暂无昵称

    请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表:
    终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的

    DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的

    3

    展开3条回复
共317条页码: 1/32页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分